| P/E (FY) | — | Sales (TTM) | $825.4M |
| Earnings (TTM) | -$60.0M | ROE | −19.34% |
| Net Margin | −11.21% | ROIC | −11.67% |
| Debt / Equity | 0.35 | TD / EBITDA | — |
| EPS Growth 3Y | — | Sales Growth 3Y | 21.30% |
Orthofix Medical is a medical technology company operating in the United States, Italy, the United Kingdom, France, Germany, Brazil, and internationally through Global Spine and Global Limb Reconstruction segments. The Global Spine segment makes bone growth stimulation devices, spinal fixation implants, and bone graft substitutes such as demineralized bone matrices, cellular allografts, and synthetic void fillers, along with navigation-related products for spinal, orthopedic, and dental conditions.
| Market Cap | $495.6M | Trading Days | 5292 |
| 52W High | 16.99 |
| 52W Low | 8.85 |
| % Off High | −27.84% |
| YTD | −19.13% | 1Y | 7.54% |
| 3Y | −36.61% | 5Y | −68.42% |
| 10Y | −74.06% | Since incept. (ann.) | −5.82% |
Global Spine 84% · Global Limb Reconstruction 16%
| Ann. Volatility (1Y) | 46.62% | Ann. Volatility (3Y) | 48.44% |
| Sharpe (1Y) | 0.39 | Sharpe (3Y) | −0.08 |
| Max Drawdown (1Y) | −44.86% | Max Drawdown (3Y) | −58.10% |
| Beta (3Y, vs SPY) | 1.03 |
| Ticker | Name | Mkt cap | P/E |
|---|---|---|---|
| SI | SHOULDER INNOVATIONS, INC. | $502.9M | — |
| KIDS | ORTHOPEDIATRICS CORP | $509.6M | — |
| NPCE | NeuroPace Inc | $521.6M | — |
| CLPT | ClearPoint Neuro, Inc. | $435.7M | — |
| CERS | CERUS CORP | $585.1M | — |
| ANGO | ANGIODYNAMICS INC | $592.7M | — |
| PMI | Picard Medical, Inc. | $405.8M | — |
| DCTH | DELCATH SYSTEMS, INC. | $398.7M | 165.0 |
| TCMD | TACTILE SYSTEMS TECHNOLOGY INC | $625.7M | 33.8 |
| MDXG | MIMEDX GROUP, INC. | $649.4M | 13.6 |
| MOBI | Mobia Medical, Inc. | $370.1M | — |
| SGP |
| SpyGlass Pharma, Inc. |
| $696.1M |
| — |
